
    
      The primary objective is to compare the benefit of intervention by e-health (phone
      consultation with a professional or connected objects (smartphone or tablet)) with the
      standard follow up of the pain intensity of patients 4 days (D4) after un breast biopsy.

      This study is a Monocentric, prospective, open-labeled, randomized controlled trial. A total
      of 192 patients (64 patients in group control vs 64 patients in experimental group 1 (PRO
      gathered via a phone consultation) and 64 patients in experimental group 2 (e-PRO
      self-completed via connected objects (tablet/phone) will be required including 10% of
      lost-to-follow-up patients.

      The inclusion period would be 8 months
    
  